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Background: Cardiac dysfunction is well-described in endotoxemia and diagnosed in up to 60% of patients with
endotoxic shock. ATP-sensitive potassium (KATP) channels are critical to cardiac function. This study investigates the
role of Kir6.2 subunits of KATP channels on cardiac dysfunction in lipopolysaccharide (LPS)-induced endotoxemia.
Methods: Kir6.2 subunits knockout (Kir6.2−/−) and wild-type (WT) mice were injected with LPS to induce
endotoxemia. Cardiac function was monitored by echocardiography. Left ventricles were taken for microscopy
(both light and electron) and TUNEL examination. Serum lactate dehydrogenase (LDH) and creatine kinase (CK)
activities, and tumor necrosis factor-α (TNF-α) levels in both serum and left ventricular tissues were determined.
Results: Compared to WT, Kir6.2−/− mice showed significantly declined cardiac function 360 min after LPS
administration, aggravated myocardial damage and elevated serum LDH and CK activities. Apoptotic cells were
obviously increased in heart tissues from Kir6.2−/− mice at 90, 180 and 360 min. TNF-α expression in both serum
and heart tissues of Kir6.2−/− mice was significantly increased.
Conclusions: We conclude that Kir6.2 subunits are critical in resistance to endotoxemia-induced cardiac
dysfunction through reducing myocardial damage by inhibition of apoptosis and inflammation. KATP channels
blockers are extensively used in the treatment of diabetes, their potential role should therefore be considered in
the clinic when patients treated with antidiabetic sulfonylureas are complicated by endotoxemia.
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Endotoxemia is one of the leading causes of death in the
critically ill patients [1]. Cardiac dysfunction is well-
described in endotoxemia and diagnosed in up to 60% of
patients with endotoxic shock [2]. More importantly, car-
diac dysfunction is one of the key manifestations in clinical
endotoxemia that contributes to significant morbidity and
mortality in patients in intensive care units [3].
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reproduction in any medium, provided the orresponsible for myocardial dysfunction in the setting of
endotoxemia remain to be unraveled. It is suggested that
pro-inflammatory cytokines, such as tumor necrosis
factor-α (TNF-α), act directly or indirectly to depress car-
diac function resulting in endotoxemia-induced myocar-
dial dysfunction [4,5], and inhibition of the production of
inflammatory mediators in the heart attenuates lipopoly-
saccharide (LPS)-induced myocardial dysfunction [6].
Apoptosis plays an important role in LPS-induced cardiac
dysfunction; inhibition of cardiac apoptosis pharmaco-
logically by various treatments prevents LPS-induced
myocardial dysfunction [7,8]. Convincing evidence sug-
gests that myocardial dysfunction is closely related to pro-
inflammatory cytokines and cardiac apoptosis.
The ATP-sensitive potassium (KATP) channel is an
octameric (4:4) complex of two different types of proteind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Kir6.2) and a sulfonylurea receptor (SUR1 or SUR2) [9].
The cardiac KATP channels are composed of Kir6.2 sub-
units in combination with SUR2A [10]. Studies suggest
that opening KATP channels prevents activation of inflam-
mation and production of a variety of pro-inflammatory
factors in microglial cells [11], and blocks cardiocyte apop-
tosis in ischemia-reperfusion [12]. KATP channels are also
believed to play an essential role in cardiovascular adaptive
response under the challenge of stress [13]. Furthermore,
Buckley et al. proposed that KATP channels opening might
actually represent a protective mechanism against cellular
damage in endotoxemia [10]. However, the role of Kir6.2
subunits of KATP channels in endotoxemia-induced car-
diac dysfunction is unknown. We hypothesized that the
Kir6.2 subunits protects cardiac function through redu-
cing myocardial damage by inhibition of apoptosis and
inflammation in endotoxemia. In this work, using Kir6.2−/−
mice, the role of Kir6.2 on cardiac dysfunction was investi-
gated in LPS-induced endotoxemia.
Methods
Experimental animals
Male mutant mice (20–25 g) lacking Kir6.2-containing
KATP channels were generated by targeted disruption of the
gene coding for Kir6.2 in the Model Animal Research
Center of Nanjing University (AAALAC accredited). Wild-
type (WT) littermates were used as controls. Knockout of
the Kir6.2 gene was confirmed by RT-PCR (Additional files
1, 2 and 3: Figure S1-S3). Animals were housed under con-
ditions of controlled temperature (22-24°C), 12-h light and
12-h dark cycles (8:00–20:00 light, 20:00–8:00 dark), with
free access to food and tap water. All the animals used in
this work received humane care in compliance with the
institutional animal care guidelines and the Guide for Care
and Use of Laboratory Animals published by the National
Institutes of Health.
Endotoxemia model
The endotoxemia was modeled by administration of LPS
(Escherichia coli, 0111:B4, Sigma Chemical Co.) referred
to previous studies [14,15]. Briefly, LPS was dissolved in
sterile saline to a concentration of 1.0 mg/ml. Mice
(both WT and Kir6.2−/−) were injected with LPS 20 mg/
kg intraperitoneally to induce endotoxemia. Mice that
were treated with sterile saline served as control.
Echocardiography
Echocardiographic assessment of cardiac function in
mice was examined as described previously [16]. Mice were
lightly anesthetized with isoflurane in 100% oxygen 360
min after LPS injection. Transthoracic echocardiography
was performed using a 30 MHz high frequency scanhead
(VisualSonics Vevo770, VisualSonics Inc. Toronto, Canada).All measurements were averaged for five consecutive car-
diac cycles. Echocardiographic assessment of left ventricular
ejection fraction (EF) and fraction of shortening (FS) was
performed.Light and electron microscopy
Changes of left ventricles were examined morphologic-
ally as described previously [17]. Mice were anesthetized
with pentobarbital sodium (100 mg/kg). Hearts were
removed 90 min, 180 min and 360 min after LPS admin-
istration. The left ventricles were immersed in a 4% solu-
tion of paraformaldehyde in PBS and were fixed in this
solution for 24 h. For light microscopy, tissues were
washed, dehydrated in a graded ethanol series and em-
bedded in paraffin. Sections (4 μm) were cut trans-
versely, and then stained with hematoxylin and eosin
(HE) for light microscopic investigation at a final magni-
fication of 400. For electron microscopy, tissues were
fixed as described above and then postfixed with os-
mium tetraoxide, dehydrated in a graded ethanol series
and embedded in epoxy resin. Samples were sectioned
(50 nm), counterstained with uranyl acetate and lead cit-
rate and observed with a Hitachi H-800 Transmission
Electron Microscope (Hitachi, Japan).TUNEL study
Apoptotic changes of the left ventricle were analyzed by a
TUNEL method with a commercial kit (Boehringer
Mannheim, Mannheim, Germany). Sections (5 μm thick-
ness) were collected on glass slides coated with poly L-
lysine. The nuclear DNA fragmentation of apoptotic cells
was labeled in situ using the TUNEL method. Briefly the
sections were first deparaffinized and treated 15 min with
20 mg/ml proteinase K (Boehringer Mannheim) in 0.1
mol/L Tris–HCl buffer (pH 7.4). They were then treated
with 2% hydrogen peroxide for 5 min and incubated with
0.3 U/ml TdT buffer (Life Technologies, Gaithersburg,
MD, USA) and 0.04 nmol/ml biotinylated dUTP
(Boehringer Mannheim) in TdT buffer at 37°C for 60 min.
The sections were incubated for 10 min with 2% bovine
serum albumin, followed by 30 min in peroxidase-
conjugated streptavidin (DAKO, Carpinteria, CA, USA)
diluted 1: 300 with phosphate-buffered saline. Peroxidase
activity in the sections was visualized by the addition of
0.025% 3, 3-diaminobenzidine tetrahydrochloride in 0.05
mol/L Tris–HCl buffer (pH 7.4) solution containing 0.01%
hydrogen peroxide for 5 min. Omission of the TdT
enzyme in the TUNEL reaction was used as a negative
control and resulted in no staining. Tonsil tissue was used
as a positive control. Apoptosis was evaluated by
computer-assisted image analysis system (LEICA QUIPS,
LEICA Imaging Systems LTD, England) and the results
were calculated as the number of positive-staining nuclei
Figure 1 Unchanged Kir6.1 subunits expression in heart tissues in
Kir6.2−/− mice. Data are expressed as means ± SEM (n=3 per group).
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domly selected from each specimen [18].
CK and LDH analysis
Mice were anesthetized with pentobarbital sodium (100
mg/kg), blood samples were collected 360 min after LPS
administration and stored at 4°C for 24 h. Then the sam-
ples were centrifuged at 3,000 g for 10 min at 4°C, and
the serum was collected. Serum CK and LDH activities
were measured by using commercial kits (Shanghai
Changzheng Biotech Ltd, China).
Enzyme linked immunosorbent assay
Blood samples were collected 90, 180 and 360 min after
LPS administration, and centrifuged at 3,000 g for 10 min
at 4°C to collect serum. The serum was kept at −80°C until
analyzed. The levels of TNF-α was measured with commer-
cial ELISA kits (R&D Systems, Minneapolis, MN, USA).
Left ventricles were harvested 360 min after LPS
administration and washed three times in PBS, homoge-
nized, centrifuged at 11,000 g at 4°C for 15 min, and the
supernatant was obtained. Protein was quantified with a
BCA Protein Assay Kit (Tiangen, Beijing, China) and
then the levels of TNF-α was measured with commercial
ELISA kits (R&D Systems, Minneapolis, MN, USA).
Western blot analysis
Protein extraction and concentration determination were
the same as described in ELISA. Samples of about 30 μg
were run on 10% SDS-PAGE. The proteins were then
electrotransferred to nitrocellulose filter membranes. The
membranes were incubated in PBS containing 5% non-fat
dry milk for 4 h at 25°C. The blots were then incubated
for 2 h at 25°C with primary antibodies for Kir6.1 (1:200;
Alomone Labs Ltd, Israel), and then incubated with IRDye
800CW-conjugated goat anti-rabbit secondary antibody
(1:5,000; Rockland, USA) for 1 hour at 25°C. The infrared
fluorescence image was obtained using Odyssey infrared
imaging system (Li-Cor Bioscience, Lincoln, NE), and the
band were quantified by Image J software (NIH, USA).
Statistical analysis
Values are expressed as mean ± SEM. Differences bet-
ween two groups were evaluated by Student’s unpaired
t-test. P<0.05 was considered statistically significant.
Results
Kir6.1 subunits keeps unchanged in heart tissues of
Kir6.2−/− mice
To examine whether the expression of Kir6.1 subunits of
KATP channels were compensatory altered by genetic
ablation of Kir6.2, we compared the expression of Kir6.1
subunits in the left ventricular tissues between WT and
Kir6.2−/− mice, and found that levels of Kir6.1 subunitswere similar between the two groups (1.1 ± 0.09 vs 1.0 ±
0.03, n=3, Figure 1).
Kir6.2−/− deteriorates cardiac function
As is shown in Figure 2A, the effects of Kir6.2 subunits on
cardiac function was assessed with or without LPS treat-
ment (n=10 per group). Echocardiographic examination
showed that the baseline values of cardiac function,
assessed by EF and FS, were similar between WT and
Kir6.2−/− mice though the values of Kir6.2−/− mice were
slightly lower. LPS treatment caused significant increase of
both EF (86 ± 3 vs 73 ± 4 percent, P<0.05, Figure 2B) and
FS (55 ± 4 vs 41 ± 3 percent, P<0.05, Figure 2C) when
compared with the baseline value in WT mice. However,
LPS treatment resulted in lesser EF (56 ± 3 vs 66 ± 2 per-
cent, P<0.05, Figure 2B) and FS (28 ± 2 vs 35 ± 1 percent,
P<0.05, Figure 2C) in Kir6.2−/− mice.
Kir6.2−/− aggravates myocardial damage
To examine the role of Kir6.2 in the pathologic process
of myocardial impairment during endotoxemia, histo-
logical analysis were performed 360 min after LPS chal-
lenge (n=6 in each group). Morphological examination
displayed no significant differences in heart tissues of
WT and Kir6.2−/− mice under both light and electron
microscopy levels. After LPS challenge, hearts from WT
mice displayed a mild feature of myocardial damage, in-
cluding irregular arrangement and mild degeneration of
cardiocytes and slight rupture of myocardial fibers. Con-
sistent with the results from light microscopy, electron
microscopic examination showed similar phenomena.
After LPS challenge, the ultrastructure of cardiocytes in
WT mice showed disarray with swollen, vagueness of
the mitochondrial membrane and amorphous deposit-
laden mitochondria. Compared with these changes
found in time-matched WT mice, these lesions were
considerably more severe in Kir6.2−/− mice (Figure 3).
Figure 2 Lack of Kir6.2 subunits deteriorates cardiac function in mice following LPS treatment (A, representative echocardiograms).
Unlike WT mice, Kir6.2−/− mice failed to augment cardiac performance 360 min after LPS administration, and progressed to significant depression
of ventricular function as determined by left ventricular ejection fraction (EF, B) and fraction of shortening (FS, C). *P<0.05 compared with Control
(unpaired t test). Data are expressed as means ± SEM (n=10 per group).
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the confirmation of myocardial injury, were determined
360 min after LPS administration (n=10 in each group).
Lack of Kir6.2 subunits itself did not influence the levels
of LDH and CK when compared with WT mice. LPS
challenge induced greater levels of LDH and CK in WTFigure 3 Morphological analysis of myocardial damage in WT and Kir
and electron micrographs of the left ventricular tissues indicate that LPS-indu
mice than in WT mice (n = 6 per group). Mt, mitochondria; Mf, myofiber.and Kir6.2−/− mice. Furthermore, the level of serum
LDH in Kir6.2−/− mice was significantly higher than in
WT mice serum (1787 ± 137 U/L vs 507 ± 52 U/L,
P<0.01, Figure 4A). Similarly, serum CK level was also
greater in Kir6.2−/− group (2271 ± 218 U/L vs 644 ± 49
U/L, P<0.01, Figure 4B).6.2−/− mice 360 min after LPS administration. Representative light
ced endotoxemia caused more severe myocardial damage in Kir6.2−/−
Figure 4 Serum lactate dehydrogenase (LDH, A) and creatine kinase (CK, B) levels were significantly elevated in Kir6.2−/− mice
following LPS treatment. **P<0.01 compared with WT (unpaired t test); #P<0.05, ##P<0.01 compared with Control (unpaired t test). Data are
expressed as means ± SEM (n=10 per group).
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Apoptosis has been recognized as a major contributor in
endotoxemia-induced cardiac dysfunction. Thus, the role of
Kir6.2 in myocardial apoptosis was examined. Apoptotic
cells were only occasionally appeared in sections of left ven-
tricles in either WT or Kir6.2−/− mice. LPS injection caused
significant apoptosis in both kinds of mice. However, apop-
totic cells were significantly greater at 90 min (29 ± 1.6 vs
24 ± 1.5, P<0.05, n=6), 180 min (35 ± 1.2 vs 24 ± 2.5, P<0.01,
n=6) and 360 min (26 ± 0.4 vs 13 ± 2.5, P<0.01, n=6) in
Kir6.2−/− mice than time-matched WT ones (Figure 5).
Kir6.2−/− increases serum and myocardial TNF-α levels
The basic serum and myocardial TNF-α levels in WT
mice were undetectable, Kir6.2−/− did not influence theseFigure 5 Lack of Kir6.2 subunits exacerbates myocardial apoptosis in m
Arrow indicates TUNEL positive cells. *P<0.05, **P<0.01 compared with WTvalues. Serum TNF-α expression increased rapidly after
LPS injection and then tended to decrease. No significant
differences were found at 90 min and 180 min between
WT and Kir6.2−/− mice. Interestingly, serum TNF-α kept
in a higher level in Kir6.2−/− mice at 360 min after LPS
treatment when compared with the time-matched WT
mice (459 ± 34 pg/ml vs 190 ± 21 pg/ml, n=10, P<0.01,
Figure 6A). LPS injection also induced greater myocardial
TNF-α level in Kir6.2−/− mice at 360 min (1510 ± 154
pg/ml vs 849 ± 89 pg/ml, n=10, P<0.01, Figure 6B).
Discussion
This study investigated the role of Kir6.2 subunits of
KATP channels in endotoxemia-induced cardiac dysfunc-
tion. The main findings are: cardiac dysfunction andice at 90, 180 and 360 min after LPS administration (TUNEL × 400).
(unpaired t test). Data are expressed as means ± SEM (n=6 per group).
Figure 6 Serum (A) and myocardial (B) TNF-α levels were significantly elevated in Kir6.2−/− mice following LPS treatment. Kir6.2−/− mice
displayed greater TNF-α level in both serum and myocardial tissues than WT mice 360 min after LPS administration. **P<0.01 compared with WT
(unpaired t test). Data are expressed as means ± SEM (n=10 per group).
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under LPS-induced endotoxemia. These suggested that
Kir6.2 subunits might play a protective role under infec-
tious diseases.
Kir6.1 subunits expression in the heart
Despite the concept of Kir6.2 and SUR2A subunits as
the major molecular component of “cardiac” KATP chan-
nels [10], evidences also support that Kir6.1 is expressed
in the heart of mice, and Kir6.1 and Kir6.2 may assemble
into functional channel complexes [19,20]. To exclude
the possible compensatory action produced by Kir6.1 be-
cause of Kir6.2 knockout, expression of Kir6.1 subunits
was determined in Kir6.2−/− mice. The similar protein
levels of Kir6.1 subunits in the left ventricle between
WT and Kir6.2−/− mice suggested that no compensatory
increase happened for Kir6.1 subunits in the heart be-
cause of Kir6.2 knockout.
Cardiac protective effect of kir6.2 subunits in endotoxemia
Cardiac dysfunction, diagnosed in up to 60% of patients
with endotoxic shock, is a critical determinant of mor-
tality in endotoxic shock [3]. KATP channel is a kind of
molecular sensors that play a critical role in the adaptive
response to both physiological and pathological stress
[21,22]. Kir6.2 subunit is a major molecular component
of “cardiac” KATP channels. KATP channels are consid-
ered to be a potential target in regulating cardiovascular
function in endotoxemia, and the mitochondrial KATP
channels may offer protection against apoptosis in
endotoxemia [10]. Thus, the first aim of this work was
designed to assess the role of Kir6.2 subunits on cardiac
function and cardiac damage under LPS stimulation.
Our work found that LPS injection caused a marked de-
crease of cardiac function in Kir6.2−/− mice, though the
cardiac function of WT mice was compensatory in-
creased after LPS treatment. These suggested that lack
of Kir6.2 subunits in the heart might not only abolish
the compensatory enhancement of cardiac function butalso exacerbate cardiac dysfunction in endotoxic shock.
Morphological examination showed aggravated myocar-
dial damage in Kir6.2−/− mice, which was also confirmed
by the increased LDH and CK activities. To our know-
ledge, this is the first time to report that lack of Kir6.2
subunits aggravates cardiac dysfunction and myocardial
damage during endotoxemia.
Mechanisms for cardiac protective effect of kir6.2 subunits
in endotoxemia
Studies have showed that cardiocyte apoptosis played a
mechanistic role in endotoxic myocardial depression
[23,24], left ventricular myocyte apoptosis was directly in-
volved in endotoxemia-induced cardiac dysfunction [25],
and caspase inhibition prevented heart apoptosis and car-
diac dysfunction in endotoxemia [26,27]. In this study, we
found that apoptotic cadiocytes were significantly in-
creased at 90, 180 and 360 min after LPS injection in WT
and Kir6.2−/− mice. Importantly, the number of apoptotic
cadiocytes was greater in Kir6.2−/− mice than time-
matched WT ones. Though many factors may contribute
to cadiocyte apoptosis during the LPS-produced inflam-
matory process, our result demonstrated that lack of
Kir6.2 subunits increased endotoxemia-induced apoptotic
cadiocytes. These suggested that inhibition of apoptosis
might be one of the cardioprotective mechanisms medi-
ated by Kir6.2 subunits in endotoxemia.
Inflammatory response has been considered as a pivotal
factor in endotoxemia-induced cardiac dysfunction. Levels
of various pro-inflammatory cytokines, such as TNF-α,
were considered directly or indirectly contributing to car-
diac dysfunction [4]. Carlson et al. demonstrated that
caspase activation induced by TNF-α mediated endotoxin-
related cardiac dysfunction [28]. These suggested that
TNF-α signaling played a significant role on cardiac dys-
function in endotoxemia. In this study, we found that both
serum and myocardial TNF-α were significantly increased
in Kir6.2−/− mice 360 min after LPS injection when com-
pared with WT mice. Mitogen-activated protein kinases
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are considered as molecular targets for anti-inflammatory
therapy [29]. Previous study demonstrated that opening of
KATP channels prevented production of TNF-α in micro-
glial cells via inhibition of MAPKs pathways [11]. These re-
sults, together with our findings, indicated that inhibition
the production of pro-inflammatory cytokines might be an-
other cardioprotective mechanism mediated by Kir6.2 sub-
units in endotoxemia through MAPKs pathways.
Recently it was found that there was a redistribution
of coronary blood flow in the left ventricle during endo-
toxin shock in pigs, and suggested that ischemic insults
might underlie, at least in part, the cardiac dysfunction
during endotoxemia [30]. Indeed, hearts of Kir6.2−/− mice
lacked the protective effect of ischemic preconditioning
[31]. We postulate that myocardial ischemia might be
more serious in Kir6.2−/− mice than WT ones during
endotoxemia, which might be another possible mechan-
ism responsible for cardioprotective effect mediated by
Kir6.2 subunits in endotoxemia. Further study is needed
to demonstrate this hypothesis.
Clinical perspective
Given the issues raised above, it was hoped that Kir6.2
subunits played a vital role in protecting against
endotoxemia-induced cardiac dysfunction. Sulfonylureas,
a kind of KATP channels blockers, are extensively used
for most patients with type 2 diabetes [32,33]. This sug-
gests that KATP channels in patients are blocked when
drugs lack tissue specificity. Importantly, an increase of
plasma glucose may reduce cardiac KATP channels gene
expression to result in cardiac dysfunction observed in
diabetic rats [34]. Type 2 diabetes is associated with a
high risk of acquiring infectious diseases and developing
endotoxemia [35]. Thus, the present study has important
implications in the clinic with regard to the relationship
between sulfonylureas treatment and heart function for
diabetic patients suffering from endotoxemia [36].
Study limitations
Our work is focused on the in vivo characteristics of
Kir6.2 subunits in endotoxemia-induced cardiac dysfunc-
tion. To understand the mechanism of Kir6.2 subunits in
endotoxemia-induced cardiac dysfunction, further studies
with isolated cardiocytes from Kir6.2−/− mice under LPS
stimulation is needed, which may offer direct evidence
for the protective effects of Kir6.2 subunits under
endotoxemia. Besides, the influence of sulfonylureas treat-
ment on cardiac function in diabetic mice under LPS
endotoxemia also deserved further investigation.
Conclusions
That loss of Kir6.2 subunits aggravates endotoxemia-
induced cardiac dysfunction is suggestive of a previouslyunrecognized biological role of this subunit in regulating
the cardiac function, and Kir6.2 subunits of KATP chan-
nels may play an important role in resistance to
endotoxemia-induced cardiac dysfunction.
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Additional file 1: Figure S1. Kir6.2 gene expression in Kir6.2-/- mice. Total
RNA was prepared from freshly isolated left ventricle of either wild-type or
Kir6.2-/- mice. (Kir6.2 primer: sense, TCCAACAGCCCGCTCTAC; antisense,
GATGGGGACAAAACGCTG).
Additional file 2: Figure S2. Unchanged SUR2 expression in the left
ventricle of Kir6.2-/- mice.
Additional file 3: Figure S3. Representative ECG from WT and
Kir6.2-/- mice.
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